Free tool
Cell therapy stocks
We cover 8 companies grouped under the Cell therapy theme. The median market value in the group is $269.64M. Across the group, the median move over the past trading day is +0.66%. Price change over the past year runs from −49.1% to +22.5% across the middle 80 percent of the group, with a median of −33.4%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
8 of 86 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 4592.T | SanBio Company Limited | $495.75M | Small cap | −57.08% |
| 005690.KS | Pharmicell Co., Ltd. | $472.85M | Small cap | −0.03% |
| 219A.T | HEARTSEED INC | $350.89M | Small cap | −30.13% |
| 4894.T | Cuorips Inc. | $300.07M | Small cap | −15.38% |
| 4593.T | Healios K.K. | $239.21M | Small cap | −41.63% |
| 7774.T | Japan Tissue Engineering Co., Ltd. | $216.10M | Small cap | +75.00% |
| 504A.T | Innovacell Inc. | $162.36M | Small cap | −45.71% |
| OCC.AX | Orthocell Limited | $148.74M | Small cap | −36.67% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.